Price Alert

Praxis Precision Medicine... (PRAX)

NASDAQ: PRAX · Real-Time Price · USD

46.85

0.76 (1.65%)

At close: Sep 05, 2025, 3:59 PM

45.97

-1.88%

After-hours: Sep 05, 2025, 04:46 PM EDT

1.65% (1D)

Bid	44.8
Market Cap	986M
Revenue (ttm)	7.76M
Net Income (ttm)	-251.01M
EPS (ttm)	-12.4
PE Ratio (ttm)	-3.78
Forward PE	-3.75
Analyst	Buy

Ask	50.73
Volume	344,124
Avg. Volume (20D)	410,669
Open	46.58
Previous Close	46.09
Day's Range	45.81 - 47.83
52-Week Range	26.70 - 91.83
Beta	2.62

About PRAX

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol PRAX

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for PRAX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Praxis Precision Medicines Inc. is scheduled to release its earnings on Nov 5, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 month ago

-5.55%

Praxis Precision Medicines shares are trading lowe... Unlock content with Pro Subscription

6 months ago

-13.08%

Praxis Precision Mediciines shares are trading lower after multiple firms cut their respective price targets on the stock.

News

3 weeks ago · businesswire.com

PRAX Investors Have Opportunity to Join Praxis Precision Medicines, Inc. Fraud Investigation with the Schall Law Firm

LOS ANGELES--(BUSINESS WIRE)---- $PRAX--PRAX Investors Have Opportunity to Join Praxis Precision Medicines, Inc. Fraud Investigation with the Schall Law Firm.

1 month ago · seekingalpha.com

Praxis Precision Medicines, Inc. (PRAX) Q2 2025 Earnings Call Transcript

Praxis Precision Medicines, Inc. (NASDAQ:PRAX ) Q2 2025 Earnings Conference Call August 4, 2025 8:30 AM ET Company Participants a - Corporate Participant Marcio Silva De'Souza - President, CEO & Direc...

1 month ago · fool.com

Praxis (PRAX) Q2 Loss Widens 90%